Williams Jones & Associates’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,942
Closed -$1.32M 433
2018
Q3
$1.32M Buy
6,942
+4,822
+227% +$886K 0.03% 196
2018
Q2
$353K Sell
2,120
-7,975
-79% -$1.28M 0.01% 330
2018
Q1
$1.7M Buy
+10,095
New +$1.69M 0.04% 188
2017
Q4
Sell
-23,369
Closed -$4.79M 453
2017
Q3
$4.79M Sell
23,369
-2,545
-10% -$592K 0.12% 124
2017
Q2
$6.3M Buy
25,914
+742
+3% +$174K 0.16% 110
2017
Q1
$6.01M Sell
25,172
-3,099
-11% -$722K 0.16% 118
2016
Q4
$5.94M Sell
28,271
-56,931
-67% -$11.8M 0.17% 118
2016
Q3
$19.6M Sell
85,202
-25,342
-23% -$6.19M 0.57% 57
2016
Q2
$25.5M Buy
110,544
+1,242
+1% +$286K 0.79% 40
2016
Q1
$29.3M Sell
109,302
-8,515
-7% -$2.44M 1.37% 21
2015
Q4
$36.8M Sell
117,817
-120,486
-51% -$35.9M 1.68% 16
2015
Q3
$64.8M Sell
238,303
-10,448
-4% -$3.21M 2.91% 4
2015
Q2
$75.5M Buy
248,751
+17,053
+7% +$5.09M 2.9% 5
2015
Q1
$69M Buy
231,698
+65,432
+39% +$18.7M 2.77% 6
2014
Q4
$42.8M Buy
166,266
+33,362
+25% +$8.34M 1.76% 12
2014
Q3
$32.1M Buy
132,904
+82,488
+164% +$18.5M 1.46% 16
2014
Q2
$11.2M Sell
50,416
-34,860
-41% -$7.22M 0.5% 52
2014
Q1
$17.6M Buy
+85,276
New +$16.9M 0.35% 74

Other funds holding AGN

Williams Jones & Associates's AGN Position: Q4 2018 in Review

Williams Jones & Associates sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 6,942 shares — an estimated $1.32M sold.

Williams Jones & Associates first reported a position in AGN in Q1 2014 and held it in 18 quarters. The position peaked at $75.5M in Q2 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Williams Jones & Associates reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Williams Jones & Associates sold 6,942 Allergan plc shares in Q4 2018, an estimated $1.32M.
  • Williams Jones & Associates first reported a position in Allergan plc in Q1 2014 and held it in 18 quarters.
  • Williams Jones & Associates's Allergan plc position peaked at $75.5M in Q2 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Williams Jones & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.